πŸ‡ΊπŸ‡Έ FDA
Patent

US 12233086

Biomarkers for neurogenerative disease

granted A61KA61K33/20A61P

Quick answer

US patent 12233086 (Biomarkers for neurogenerative disease) held by The Regents of the University of California expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K33/20, A61P, A61P25/28